Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy
Status:
Recruiting
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
This study plans to observe the changes of liver cancer and immune cell subsets by
replicating the high abundance intestinal flora and liver cancer mouse model, reveal the
relationship and mechanism of intestinal flora in the immunotherapy of liver cancer, and
study the impact on prognosis by regulating the positive correlation of lactic acid bacteria
and bifidobacteria of rumen coccus in patients with advanced liver cancer receiving
immunotherapy